IMR Press / RCM / Special Issues / 1637717615646

Advances in Treatment of Ventricular Tachycardia in Patients with Structural Heart Disease

Submission deadline: 15 August 2022
Special Issue Editor
  • Jackson J. Liang, DO
    Division of Cardiovascular Medicine, Cardiac Arrhythmia Service, University of Michigan, Ann Arbor, MI, USA
    Interests: Ventericular tachycardia; Ventricular fibrillation; Catheter ablation; PVC; Sudden death
Special Issue Information

Dear Colleagues,

Sudden death is a common cause of mortality in patients with ischemic and non-ischemic cardiomyopathy. Although implantable cardioverter defibrillators (ICDs) have reduced the risk of sudden death due to ventricular arrhythmias, recurrent ventricular tachycardia (VT) may result in ICD shocks that can substantially affect patient quality of life. Antiarrhythmic drug therapy and catheter ablation are the most frequent and scientifically proven strategies to reduce VT burden. Additionally, novel alternative strategies for VT management such as neuromodulation, noninvasive radiation ablation, coronary venous and arterial ethanol ablation, and surgical/hybrid ablation are increasingly being used for certain patients with VT. This Special Issue is specifically aimed at presenting the current status of VT management in patients with structural heart disease. It will cover VT substrates in patients with different types of cardiomyopathies, techniques and outcomes of catheter ablation, strategies to improve safety and efficacy of ablation, as well as alternative and adjunctive novel VT management strategies.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.


Dr. Jackson J. Liang

Guest Editor

Keywords
Ventricular tachycardia
Cardiomyopathy
Catheter ablation
Arrhythmia
Neuromodulation
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Back to top